GNAO1

Clinical trials for GNAO1 explained in plain language.

Never miss a new study

Get alerted when new GNAO1 trials appear

Sign up with your email to follow new studies for GNAO1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for kids with rare epilepsy: experimental drug targets root cause

Disease control Recruiting now

This study tests an experimental drug called ASO-GNAO1 (Tianasen) in 5 children aged 1-14 with a specific genetic form of epilepsy and movement disorders. The drug is given via spinal injection over 12 months to see if it can reduce seizures and improve symptoms. Because the dise…

Matched conditions: GNAO1

Phase: PHASE1, PHASE2 • Sponsor: Pirogov Russian National Research Medical University • Aim: Disease control

Last updated May 17, 2026 05:31 UTC

GNAO1

Get alerted when new GNAO1 trials appear

New hope for kids with rare epilepsy: experimental drug targets root cause